(Q44803518)

English

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

0 references

1 reference

based on heuristic

inferred from title

chronic renal insufficiency

1 reference

based on heuristic

inferred from title

12

object named as

P W F Wilson

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

B Kasiske

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

F G Cosio

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

J Beto

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

K Bolton

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

B M Chavers

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

R Grimm

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

A Levin

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

B Masri

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

R Parekh

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

C Wanner

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

D C Wheeler

11

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

National Kidney Foundation

13

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

number of pages

41

1 reference

based on heuristic

inferred from page(s)

American Journal of Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

4 Suppl 7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

13-53

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

C-reactive protein and chronic Chlamydia pneumoniae infection--long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Aspirin for the primary prevention of cardiovascular events: recommendation and rationale

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Cholesterol lowering in atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Ongoing clinical trials of statins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vasc

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Carotid atherosclerosis in renal transplant recipients: relationships with cardiovascular risk factors and plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Carotid atherosclerosis in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Effect of lipid reduction on the progression of renal disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

The effect of pravastatin on acute rejection after kidney transplantation--a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

The effects of lipid-lowering agents on acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Effect of lovastatin, an HMG CoA reductase inhibitor, on acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Hypertension-related renal injury: a major contributor to end-stage renal disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Progression of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Hyperlipidaemia in renal transplant patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Weight change and serum lipoproteins in recipients of renal allografts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Arterial changes in paediatric haemodialysis patients undergoing renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients(1).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Utility of direct measurement of low-density lipoprotein cholesterol in dyslipidemic pediatric patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Usefulness of lipoprotein changes during acute coronary syndromes for predicting postdischarge lipoprotein levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Serum lipids after stroke.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Changes in serum lipoprotein pattern induced by acute infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Transient reductions in serum cholesterol after renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Assignment of the human PHLDA1 gene to chromosome 12q15 by radiation hybrid mapping

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Changes in the composition and physico-chemical characteristics of serum lipoproteins during ethanol-induced lipaemia in alcoholic subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Alcohol and blood lipids. The cooperative lipoprotein phenotyping study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus G

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: a meta-analysis of randomized, controlled trials.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Safety and efficacy of simvastatin for hyperlipidemia in renal transplant recipients: a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

The pharmacokinetics of pravastatin in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Single-dose pharmacokinetics of 14C-lovastatin in chronic renal failure.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

The short term effects of bezafibrate on the hypertriglyceridaemia of moderate to severe uraemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Pleiotropic effects of statins: do they matter?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Statins and the acute-phase response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Placing PRINCE in perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

The interaction of diltiazem with simvastatin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Potential interaction between troglitazone and atorvastatin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Bile acid binding to sevelamer HCl.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Hypertriglyceridemia as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Severe reversible renal failure with bezafibrate.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

CORONARY DISEASE AMONG UNITED STATES SOLDIERS KILLED IN ACTION IN KOREA

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Risk factors for cardiovascular disease in renal transplant recipients: new insights.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Plant stanol ester and bran fiber in childhood: effects on lipids, stool weight and stool frequency in preschool children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

The design of a prospective study of pravastatin in the elderly at risk (PROSPER)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Effect of fluconazole on plasma fluvastatin and pravastatin concentrations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Biological variations in hyperlipidemic children and adolescents treated with fenofibrate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6135.2004.0355.X

21 January 2018

Identifiers

10.1111/J.1600-6135.2004.0355.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44803518&oldid=2091698672"